3 Results for "

1051375-13-3

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "1051375-13-3" in MCE Product Catalog:

14
14 Cited Publications
Cat. No.: HY-15592A
CAS No.: 1051375-13-3
Purity:  99.87%
Synonyms: GSK-1265744 sodium; S/GSK1265744 sodium
Target:  

OAT HIV HIV Integrase

Research Areas:  

Infection

Cabotegravir (GSK-1265744) sodium is a orally active and long-acting HIV integrase strand transfer inhibitor and organic anion transporter 1/3 (OAT1/OAT3) inhibitor with IC50 values of 2.5 nM, 0.41 μM and 0.81 μM for HIVADA, OAT3 and OAT1, respectively. Cabotegravir sodium is primarily metabolized by uridine diphosphate glucuronosyltransferase (UGT) 1A1, with low potential to interact with other antiretroviral agents (ARVs). Cabotegravir sodium can be used to research AIDS .
loading...
    loading...
14
14 Cited Publications
Cat. No.: HY-15592
CAS No.: 1051375-10-0
Purity:  99.91%
Synonyms: GSK-1265744; S/GSK1265744
Target:  

OAT HIV HIV Integrase

Research Areas:  

Infection

Cabotegravir (GSK-1265744) is a orally active and long-acting HIV integrase strand transfer inhibitor and organic anion transporter 1/3 (OAT1/OAT3) inhibitor with IC50 values of 2.5 nM, 0.41 μM and 0.81 μM for HIVADA, OAT3 and OAT1, respectively. Cabotegravir is primarily metabolized by uridine diphosphate glucuronosyltransferase (UGT) 1A1, with low potential to interact with other antiretroviral agents (ARVs). Cabotegravir can be used to research AIDS .
loading...
    loading...
Cat. No.: HY-15592AS
Synonyms: GSK-1265744-d3 sodium; S/GSK1265744-d3 sodium
Cabotegravir-d3 (sodium) is the deuterium labeled Cabotegravir sodium. Cabotegravir sodium is a highly potent HIV integrase inhibitor with an IC50 value of 2.5 nM for HIVADA. Cabotegravir sodium is primarily metabolized by uridine diphosphate glucuronosyltr
loading...
    loading...